Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 287.0 | 67 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 75.0 | 70 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 118.0 | 69 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 157.0 | 62 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | MIP-1B | 147.0 | 51 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MIP-1B | 55.5 | 66 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MIP-1B | 62.0 | 79 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MIP-1B | 51.0 | 82 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MIP-1B | 58.5 | 82 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MIP-1B | 63.0 | 70 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MIP-1B | 61.0 | 66 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MIP-1B | 166.0 | 71 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | MIP-1B | 270.0 | 67 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MIP-1B | 70.0 | 69 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | MIP-1B | 88.5 | 64 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MIP-1B | 1105.0 | 78 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | MIP-1B | 1054.0 | 81 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | MIP-1B | 61.0 | 70 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | MIP-1B | 61.0 | 74 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | MIP-1B | 59.0 | 75 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | MIP-1B | 58.5 | 98 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | MIP-1B | 59.0 | 69 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | MIP-1B | 58.5 | 72 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | MIP-1B | 59.0 | 75 | ||||
RA2159 | 2 | MIP-1B | 59.0 | 54 |